Inc., a medical device company developing a minimally invasive treatment for lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), today announced the successful ...
Extendicare Inc. ("Extendicare" or the "Company") announced today that it plans to release its financial results for the fourth quarter of 2024 after market close on Thursday, February 27, 2025. A ...
A MAN suffering from a common cancer was forced to have his entire penis amputated after it spread to his manhood, in what medics described as an “exceedingly rare” case. The ...